| Name | 1-cyclopropyl-6-fluoro-7-piperazin-1-ylquinolin-4-one |
|---|---|
| Synonyms |
1-Cyclopropyl-6-fluoro-7-(piperazin
Decboxy Ciprofloxacin Ciprofloxacin IMpurity E //BP 1-Cyclopropyl-6-fluoro-7-(piperazin-1-yl)quinolin-4(1H)-one (Decboxylated Compound) Ciprofloxacin Impurity E(HCl) 7-(piperazin-1-yl)-1-cyclopropyl-6-fluoroquinolin-4-one Ciprofloxacin Hydrochloride Impurity E Ciprofloxacin Impurity EQ: What is Ciprofloxacin Impurity E Q: What is the CAS Number of Ciprofloxacin Impurity E Q: What is the storage condition of Ciprofloxacin Impurity E Q: What e the applications of Ciprofloxacin Impurity E 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oyo-7(1-piperazinyl)-quinoline 1-Cyclopropyl-6-fluoro-7-(piperazin-1-yl)quinolin-4(1H)-one Ciprofloxacin ImpuritⅤ:(Ciprofloxacin Impurity E)1-Cyclopropyl-6-fluoro-7-(piperazin-1-yl)quinolin-4(1H)-one Ciprofloxacin IMpurity E Ciprofloxacin Impurity E HClQ: What is Ciprofloxacin Impurity E HCl Q: What is the CAS Number of Ciprofloxacin Impurity E HCl Q: What is the storage condition of Ciprofloxacin Impurity E HCl Ciprofloxacin Impurity-E (Decboxy Ciprofloxacin) Ciprofloxacin impurity 4/Ciprofloxacin Impurity E/ Decboxy Ciprofloxacin/1-cyclopropyl-6-fluoro-7-(piperazin-1-yl)quinolin-4(1H)-one 4(1H)-Quinolinone, 1-cyclopropyl-6-fluoro-7-(1-piperazinyl) Fluoroquinolonic acid E 1-cyclopropyl-6-fluoro-7-(1-piperazinyl)-4(1H)-quinolinone 1-Cyclopropyl-6-fluoro-7-(1-piperazinyl)-4(1H)-quinolinone Ciprofloxacin Impurity E/Decboxy Ciprofloxacin Ciprofloxacin Hydrochloride Impurity Ⅴ:Ciprofloxacin Impurity E SQ-4002 Ciprofloxacin Impurity 5(Ciprofloxacin Impurity E) |
| Density | 1.327g/cm3 |
|---|---|
| Boiling Point | 496.641ºC at 760 mmHg |
| Molecular Formula | C16H18FN3O |
| Molecular Weight | 287.33200 |
| Flash Point | 254.159ºC |
| Exact Mass | 287.14300 |
| PSA | 37.27000 |
| LogP | 2.27890 |
| Vapour Pressure | 0mmHg at 25°C |
| Index of Refraction | 1.631 |
| HS Code | 2933990090 |
|---|
|
~30%
105394-83-0 |
| Literature: Marks, Kevin R.; Malik, Muhammad; Mustaev, Arkady; Hiasa, Hiroshi; Drlica, Karl; Kerns, Robert J. Bioorganic and Medicinal Chemistry Letters, 2011 , vol. 21, # 15 p. 4585 - 4588 |
|
~93%
105394-83-0 |
| Literature: Dar Al Dawa Development, and Investment Co. Patent: EP1245566 A1, 2002 ; Location in patent: Page 2-3 ; |
|
~%
105394-83-0 |
| Literature: Nguyen, Son T.; Ding, Xiaoyuan; Butler, Michelle M.; Tashjian, Tommy F.; Peet, Norton P.; Bowlin, Terry L. Bioorganic and Medicinal Chemistry Letters, 2011 , vol. 21, # 19 p. 5961 - 5963 |
|
~%
105394-83-0 |
| Literature: Helvetica Chimica Acta, , vol. 84, # 9 p. 2508 - 2519 |
| Precursor 3 | |
|---|---|
| DownStream 0 | |
| HS Code | 2933990090 |
|---|---|
| Summary | 2933990090. heterocyclic compounds with nitrogen hetero-atom(s) only. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |